News & Updates

Effective PrEP averts further cost for HIV treatment

02 Mar 2022

Effective treatment with pre-exposure prophylaxis (PrEP) for HIV puts a cap on the additional cost patients should be willing to pay for long-acting injectable cabotegravir (CAB-LA), reports a US study.

Effective PrEP averts further cost for HIV treatment

02 Mar 2022

Ligelizumab improves symptoms, QoL in patients with urticaria

02 Mar 2022 by

In patients with chronic spontaneous urticaria (CSU) who remained symptomatic despite treatment, the monoclonal anti-immunoglobulin E antibody ligelizumab improved symptom control regardless of BHRA* status, as well as dermatology quality of life (QoL) regardless of angioedema status, findings from a phase IIb study have shown.

Ligelizumab improves symptoms, QoL in patients with urticaria

02 Mar 2022

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Quantitative sensory testing (QST) yields reliable measures of pain threshold and tolerance, reveals a new study. However, measurements for sensitivity to changes in temperature are less reliable and may be affected by time and other contextual factors.

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Wearable defibrillator helps avoid sudden cardiac death after surgery

02 Mar 2022 by

Wearable cardioverter defibrillators (WCD) can effectively protect cardiac surgery patients from sudden cardiac death (SCD), according to a recent study, noting that SCD risk was substantial within the first 3 months after the procedure.

Wearable defibrillator helps avoid sudden cardiac death after surgery

02 Mar 2022

Continuity of care cuts ASCVD risk in newly diagnosed dyslipidaemic patients

02 Mar 2022

Good continuity of care (COC) helps prevent atherosclerotic cardiovascular disease (ASCVD) in patients with newly diagnosed dyslipidaemia, a recent Korea study has found.

Continuity of care cuts ASCVD risk in newly diagnosed dyslipidaemic patients

02 Mar 2022

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Patients with chronic obstructive pulmonary disease (COPD) and allied conditions are at heightened risk of stroke, but treatment with mucolytic agents and the combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) may protect against the risk, as shown in a study.

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Inattention in ADHD tied to hoarding behaviour

02 Mar 2022

Individuals with attention deficit hyperactivity disorder (ADHD) frequently exhibit hoarding behaviour, which is specifically associated with inattention, as reported in a study.

Inattention in ADHD tied to hoarding behaviour

02 Mar 2022

Too little, too much sleep tied to cognitive complaints in Chinese elderly

02 Mar 2022 by

Both longer (>8 hours) and shorter (<8 hours) sleep duration are significantly associated with worse subjective cognitive complaints (SCCs) in Chinese elderly, according to a cross-sectional study.

Too little, too much sleep tied to cognitive complaints in Chinese elderly

02 Mar 2022

I-TECH: Ivermectin found not effective against severe COVID-19 progression

02 Mar 2022 by

Ivermectin did not prevent progression to severe COVID-19 in high-risk patients with mild-to-moderate COVID-19, according to a nationwide study.

I-TECH: Ivermectin found not effective against severe COVID-19 progression

02 Mar 2022

Universal HCV screening in pregnancy: A step toward reducing transmission?

01 Mar 2022 by

Universal screening for hepatitis C virus (HCV) in pregnant individuals resulted in improved detection and a potential reduction in perinatal transmission, according to a study presented at CROI 2022.

Universal HCV screening in pregnancy: A step toward reducing transmission?

01 Mar 2022

News & Updates

Filter by Specialty:

Specialty:

Effective PrEP averts further cost for HIV treatment

Effective PrEP averts further cost for HIV treatment

Ligelizumab improves symptoms, QoL in patients with urticaria

Ligelizumab improves symptoms, QoL in patients with urticaria

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Wearable defibrillator helps avoid sudden cardiac death after surgery

Wearable defibrillator helps avoid sudden cardiac death after surgery

Continuity of care cuts ASCVD risk in newly diagnosed dyslipidaemic patients

Continuity of care cuts ASCVD risk in newly diagnosed dyslipidaemic patients

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Inattention in ADHD tied to hoarding behaviour

Inattention in ADHD tied to hoarding behaviour

Too little, too much sleep tied to cognitive complaints in Chinese elderly

Too little, too much sleep tied to cognitive complaints in Chinese elderly

I-TECH: Ivermectin found not effective against severe COVID-19 progression

I-TECH: Ivermectin found not effective against severe COVID-19 progression

Universal HCV screening in pregnancy: A step toward reducing transmission?

Universal HCV screening in pregnancy: A step toward reducing transmission?